IL2 and acute myeloblastic leukemia with maturation: Modern pharmacological studies showed that GFW could reduce the expression of vascular endothelial growth factor (VEGF), interleukin-2 (IL-2), and interleukin-8 (IL-8) in serum [11] and was found to be effective in rat models of AM [12, 13].